Royal D S M Nv ADR (RDSMY) 15.8270 $RDSMY CF Industries

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2016 at 6:16 AM

Royal D S M Nv ADR (RDSMY) 15.8270 $RDSMY

CF Industries (CF) Down to Strong Sell: Time to Dump It?
Zacks Equity Research - Zacks Investment Research - Mon May 30, 7:53AM CDT
Zacks Investment Research has downgraded fertilizer maker CF Industries (CF) to a Zacks Rank #5 (Strong Sell).
CF: 28.61 (+0.63), ALB: 80.00 (+0.16)

Sherwin-Williams Poised on Valspar Buy, FX Woes Linger
Zacks Equity Research - Zacks Investment Research - Mon May 30, 7:04AM CDT
We have issued an updated research report on paint maker Sherwin-Williams (SHW).
VAL: 108.20 (-0.04), SHW: 291.00 (-1.03)

PPG's Enhanced Windows Offering Exceptional Field Service
Zacks Equity Research - Zacks Investment Research - Thu May 26, 5:51AM CDT
PPG Industries' (PPG) enhanced-design windshields for the Airbus A320 family of jet liners have been displaying exceptional field service and reliability for airlines.
IOSP: 48.83 (-0.76), PPG: 107.67 (-0.53)

Albemarle Shares on the Upswing, Scale New 52-Week High
Zacks Equity Research - Zacks Investment Research - Tue May 17, 6:40AM CDT
Shares of Albemarle (ALB) touched a new 52-week high of $78.40 on May 16.
IOSP: 48.83 (-0.76), ALB: 80.00 (+0.16)

LyondellBasell Bumps Up Dividend, Announces Share Buyback
Zacks Equity Research - Zacks Investment Research - Mon May 16, 5:26AM CDT
LyondellBasell (LYB) has raised its quarterly dividend by 9% and declared a new 10% share repurchase program.
LYB: 79.76 (-0.82), SHI: 49.69 (+0.35)

FMC Corp. (FMC) Poised on Strategic Actions Amid Headwinds
Zacks Equity Research - Zacks Investment Research - Fri May 13, 1:13PM CDT
We have issued an updated research report on chemical company FMC Corp. (FMC).
SHI: 49.69 (+0.35), FMC: 48.85 (+0.84)

Celanese (CE) Raises Prices of Vinyl Acetate Monomer
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:27AM CDT
Celanese Corporation (CE) has announced its decision to raise the list and off-list selling prices of Vinyl Acetate Monomer, effective Jun 1, 2016.
CE: 70.67 (+0.06), IOSP: 48.83 (-0.76), SHI: 49.69 (+0.35)

DuPont (DD) Develops Advanced Anti-Counterfeiting 3D Film
Zacks Equity Research - Zacks Investment Research - Wed May 11, 2:52PM CDT
DuPont (DD) has announced a new 3D anti-counterfeiting film to make the packaging industry better equipped at preventing duplications.
IOSP: 48.83 (-0.76), DD: 68.78 (+0.68), IPHS: 39.27 (-0.23)

Albemarle (ALB) Q1 Earnings & Sales Trump, Lifts FY16 View
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:14AM CDT
Albemarle's (ALB) first-quarter earnings and revenues topped Zacks Consensus Estimates.
ALB: 80.00 (+0.16), SHI: 49.69 (+0.35)

Air Products Selling PMD Assets to Evonik for $3.8 Billion
Zacks Equity Research - Zacks Investment Research - Tue May 10, 9:00AM CDT
Air Products (APD) has agreed to divest the Performance Materials Division of its Materials Technologies segment to Evonik Industries for $3.8 billion.
SHI: 49.69 (+0.35), APD: 143.25 (-0.25)

Chemtura Expands Distribution Tie-Up with Azelis Americas
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:51AM CDT
Chemtura (CHMT) has named Azelis Americas as sole distributor for its pre-polymer urethanes, curatives and polyester polyols product lines in North America.
SHI: 49.69 (+0.35), CHMT: 26.65 (-0.03)

PPG Opens Application Development Center in Oak Creek
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:15AM CDT
PPG Industries (PPG) has opened a $3 million liquid coatings application development center at its Oak Creek, WI plant.
IOSP: 48.83 (-0.76), PPG: 107.67 (-0.53), IPHS: 39.27 (-0.23)

CF Industries (CF) Q1 Earnings Miss Estimates, Sales Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 5:56AM CDT
CF Industries (CF) posted profit of $26 million or 11 cents per share in the first quarter of 2016.
CF: 28.61 (+0.63), SMG: 70.01 (-0.02), SHI: 49.69 (+0.35)

Methanex (MEOH) Q1 Loss Wider than Expected, Sales Trail
Zacks Equity Research - Zacks Investment Research - Tue May 03, 5:04AM CDT
Methanex Corporation (MEOH) recorded loss of $23 million or 26 cents per share in the first quarter of 2016.
MEOH: 32.45 (+0.08)

FMC Corp. (FMC) Q1 Earnings Top Estimates, Ups FY16 View
Zacks Equity Research - Zacks Investment Research - Tue May 03, 4:50AM CDT
FMC Corp.'s (FMC) first-quarter earnings topped the Zacks Consensus Estimate whiles sales missed.
FMC: 48.85 (+0.84)

Praxair (PX) Beats Q1 Earnings, Down Y/Y; Revenues Lag
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 12:22PM CDT
Praxair Inc.'s (PX) for first-quarter 2016 adjusted earnings of $1.28 per share came above the Zacks Consensus Estimate of $1.26, while revenues of $2,509 million lagged our estimate of $2,537 million.
SHI: 49.69 (+0.35), PX: 110.24 (-0.32)

Eastman Chemical (EMN) Q1 Earnings Trump, Revenues Lag
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 5:24AM CDT
Eastman Chemical's (EMN) first-quarter earnings topped the Zacks Consensus Estimate while sales missed expectations.
EMN: 72.77 (-0.94)

Air Products (APD) Q2 Earnings Beat, Sales Trail; Ups View
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:04AM CDT
Air Products and Chemicals, Inc. (APD) recorded second-quarter adjusted earnings of $1.82 per share.
APD: 143.25 (-0.25)

Celanese (CE) Tops Q1 Earnings and Sales, Raises Outlook
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 8:39AM CDT
Celanese Corporation (CE) continued with its positive earnings surprise streak in first-quarter 2016 with adjusted earnings beating Zacks Consensus Estimate.
CE: 70.67 (+0.06), SHI: 49.69 (+0.35)

Dow Launches Microfoaming Technology for Rio 2016 Olympics
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:05PM CDT
The Dow Chemical Company (DOW) said that it has introduced an innovative Microfoaming Technology for the packaging industry in Latin America.
SHI: 49.69 (+0.35), DOW: 53.16 (+0.92)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...